Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, China.
Institute of Immunization Planning, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2429894. doi: 10.1080/21645515.2024.2429894. Epub 2024 Nov 29.
Human papillomavirus (HPV) is a prevalent sexually transmitted infection globally, linked to genital warts and various cancers. The burden of HPV-related diseases in males is rising significantly. We reviewed studies published until September 2024 from databases like PubMed, Embase®, and Web of Science, summarizing HPV vaccination acceptance among boys and parents in Asia and exploring influencing factors. Acceptance rates for HPV vaccination among boys ranged from 48.4% to 69.9%, while parental acceptance varied from 10.0% to 91.0%. Recent years have shown a positive trend in acceptance, influenced by perceived risk and benefits, barriers, sociodemographic characteristics, knowledge and awareness of HPV and its vaccine, and social support factors. Targeted educational interventions are crucial for increasing awareness of male-associated HPV diseases and for dispelling misconceptions. The future implementation of gender-neutral vaccination policies may facilitate broader acceptance. Future studies should focus on developing interventions to promote pan-gender HPV vaccination.
人乳头瘤病毒（HPV）在全球范围内广泛传播，与生殖器疣和各种癌症有关。男性 HPV 相关疾病的负担正在显著增加。我们检索了截至 2024 年 9 月在 PubMed、Embase®和 Web of Science 等数据库中发表的研究，总结了亚洲地区男孩和家长对 HPV 疫苗接种的接受情况，并探讨了影响因素。男孩 HPV 疫苗接种的接受率范围为 48.4%至 69.9%，而家长的接受率则从 10.0%至 91.0%不等。近年来，由于对 HPV 及其疫苗的认识、感知风险和获益、障碍、社会人口特征以及社会支持因素的影响，接种率呈上升趋势。有针对性的教育干预对于提高对男性 HPV 相关疾病的认识和消除误解至关重要。未来实施性别中立的疫苗接种政策可能会促进更广泛的接受。未来的研究应侧重于制定干预措施，以促进泛性别 HPV 疫苗接种。
